Kevin R Kaster, Age 64199 Port Royal Ave, San Mateo, CA 94404

Kevin Kaster Phones & Addresses

199 Port Royal Ave, Foster City, CA 94404 (650) 573-6718

Indianapolis, IN

San Francisco, CA

Hayward, CA

Mentions for Kevin R Kaster

Kevin Kaster resumes & CV records

Resumes

Kevin Kaster Photo 19

Kevin Kaster

Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Threshold Pharmaceuticals
Vice President, Corporate Development
Skills:
Biotechnology, Technology Transfer, Executive Management, Oncology, Trademarks, Intellectual Property, Patents, Pharmaceutical Industry, Drug Development, Biochemistry, Medical Devices, Clinical Development, Drug Discovery, Lifesciences, R&D, Molecular Biology, Commercialization, Biopharmaceuticals
Kevin Kaster Photo 20

Kevin Kaster

Publications & IP owners

Us Patents

Modified Antibiotic Resistance Gene

US Patent:
4960704, Oct 2, 1990
Filed:
May 31, 1988
Appl. No.:
7/205011
Inventors:
Thomas D. Ingolia - Indianapolis IN
Kevin R. Kaster - Indianapolis IN
R. Nagaraja Rao - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C12N 120
C12N 1500
C12N 912
C07H 1512
US Classification:
43525233
Abstract:
A modified hygromycin B resistance-conferring gene either alone or in translational reading phase with a gene or portion of a gene is disclosed. The invention further comprises recombinant DNA cloning vectors and transformants of the aforementioned DNA.

Vectors And Conditions Which Allow Genetic Transformation Of Cephalosporium

US Patent:
4762786, Aug 9, 1988
Filed:
Sep 27, 1984
Appl. No.:
6/654919
Inventors:
Jerry L. Chapman - Speedway IN
Thomas D. Ingolia - Indianapolis IN
Kevin R. Kaster - Indianapolis IN
Stephen W. Queener - Indianapolis IN
Paul L. Skatrud - Greenwood IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C12N 1500
C12N 120
C12N 114
C12P 2100
US Classification:
4351723
Abstract:
A method for transforming Cephalosporium and other lower eukaryotes is disclosed. The method involves inserting a recombinant DNA cloning vector comprising a Saccharomyces cerevisiae transcriptional and translational activating sequence positioned for expression of hygromycin phosphotransferase into a host cell and then growing the host cell under selective conditions. The vectors optionally further comprise Cephalosporium ribosomal DNA and also sequences that allow for replication and selection in E. coli and Streptomyces.

System And Method For Veryifying Audible And/Or Visual Notifications

US Patent:
2021028, Sep 16, 2021
Filed:
Mar 10, 2020
Appl. No.:
16/814200
Inventors:
- St. Michael, BB
Kirk A. Bailey - Westfield IN, US
Douglas A. Srail - Kokomo IN, US
Kevin W. Kaster - Kokomo IN, US
International Classification:
G06F 3/16
G10L 25/51
G10L 25/84
Abstract:
A method of verifying audio notifications generated within a vehicle includes generating an audio notification using an audio generation path that includes at least a controller, an audio notification generator and a speaker, wherein the controller generates an audio notification request utilized by the audio notification generator to generate an audio signal, and wherein the speaker converts the audio signal into the audio notification. The method further includes monitoring sounds within the vehicle using a microphone separate from the audio generation path and analyzing the monitored sounds using an audio analyzer, wherein the audio analyzer verifies whether the audio notification was generated. Feedback is provided to the audio generation path regarding whether generation of the audio notification was verified.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.